Table 1.
Study | Country | Season | Setting | Case definition | Interval since onset | Dominant type/subtypeb | Vaccine matchc | Time in model | Comorbid in model | % with high-risk condition |
---|---|---|---|---|---|---|---|---|---|---|
Cheng et al. [12] | Australia | 2010 | Inpatient | Admission | Unrestricted | H1pdm | Yes | Fortnight | Yes | 79% |
Levy et al. [13] | Western Australia | Outpatient | ILI | ≤4d | Week | No | NA | |||
Fielding et al. [20] | Victoria, Australia | Outpatient | ILI | ≤4d | Month | No | ||||
Kwong et al. [14] | Ontario, Canada | 2010–2011 | Inpatient | Admission | Unrestricted | H3 | Yes | Month | Yes | ≥72.8%d |
Skowronski et al. [15] | Canada | Outpatient | ILI | ≤7d | Week | Yes | 34.9% | |||
Puig-Barberàet al.a [16] | Valencia, Spain | 2011–2012 | Inpatient | ILI | Not specified | H3 | No | Week | No | 88% |
Jimenez-Jorge et al.a [17] | Spain | Outpatient | ILI | ≤7d | Week (cat) | No | 62.9% | |||
Talbot et al. [18] | Tennessee, USA | 2011–2012 | Inpatient | ARI | ≤10d | H3 | No | Onset to admission | Yes | 86% |
Ohmit et al. [19] | USA | Outpatient | ARI | ≤7d | Fortnight | Yes | 25.4% | |||
Cheng et al. [21] | Australia | 2012 | Inpatient | Admission | Not specified | H3 | No | Not specified | Yes | 83.2% |
Sullivan et al. [22] | Australia | Outpatient | ILI | Not specified | Month | No | NA | |||
Martinez-Baz et al. [10] | Narrava, Spain | 2012–2013 | Inpatient | ILI | ≤7d | B | Yes | Month | Yes | NA |
Martinez-Baz et al. [10] | Narrava, Spain | Outpatient | ILI | ≤7d | Month | Yes | NA | |||
Turner et al. [9] | Auckland, New Zealand | 2013 | Inpatient | SARI | ≤7d | H3 | Yes | Week | Yes | 64.5% |
Turner et al. [9] | Auckland, New Zealand | Outpatient | ILI | ≤7d | Week | Yes | NA | |||
Pierse et al. [23] | Auckland, New Zealand | 2014 | Inpatient | SARI | ≤7d | H1pdm | Yes | Timing of the intervention to peak of season | Yes | 51% |
Pierse et al. [23] | Auckland, New Zealand | Outpatient | ILI | ≤7d | Timing of the intervention to peak of season | Yes | 26% |
Enrolled patients targeted for influenza vaccination. Cases were positive for influenza A(H3N2) virus.
Information retrieved either from studies or the WHO website.
Information retrieved either from studies or the WHO website.
72.8% was the percentage of subjects with chronic cardiovascular disease.